SlideShare a Scribd company logo
1 of 25
WHO Analgesic Ladder
By James Kateregga
Objectives
• Review the World Health Organization (WHO) analgesic ladder
• Discuss treatment for treat mild, moderate, or severe pain
• Review additional treatment principles when using opioids
2
Background
• The WHO analgesic ladder was introduced in 1986
– 3-step ladder for adults
– Updated in 2012 to include 2-step ladder for children
• Framework for pharmacological management of pain
• 80-90% of patients are effectively treated using the WHO 3-
step approach
http://www.who.int/cancer/palliative/painladder/en/ 3
4
Mild pain
Moderate pain
Severe pain
Step 1
Non-opioid
Step 2
Weak opioid
Step 3
Strong opioid
+/- adjuvant
+/- non-opioid
+/- adjuvant
+/- non-opioid
+/- adjuvant
Consider prophylactic laxatives to avoid constipation
Step up if pain
persists
or increases
Step up if pain
persists
or increases
Non-opioids ibuprofen or other NSAID, paracetamol (acetaminophen), or aspirin
Weak opioids codeine, tramadol, or low-dose morphine
Strong opioids morphine, fentanyl, oxycodone, hydromorphone, buprenorphine
Adjuvants antidepressant, anticonvulsant, antispasmodic, muscle relaxant, bisphosphonate, or
corticosteroid
Combining an opioid and non-opioid is effective, but do not combine drugs of the same class.
Time doses based on drug half-life (“dose by the clock”); do not wait for pain to recur
Adapted by Treat the Pain from World Health Organization http://www.who.int/cancer/palliative/painladder/en/ (accessed 7 November 2013)
WHO Analgesic Ladder: adults
4
Using the WHO ladder for adults
Beating Pain, 2nd Ed. APCA (2012) 5
• Mild pain - start with a non-opioid, for example with regular paracetamol or non-
steroidal anti-inflammatory drug (NSAID), then move up steps if pain remains
uncontrolled
• Moderate - start with a weak opioid, for example, codeine or low-dose morphine
• Severe - start with a strong opioid, for example, morphine, to control pain early
• Adjuvants can be used at any step
Step 1 – mild pain: non-opioids
Paracetamol
• Adult dose: 500mg-1g by mouth every 6 hours; maximum daily
dose 4g
• Note: Hepatoxicity can occur if more than the maximum dose
is given per day
• Paracetamol can be combined with an NSAID
Beating Pain, 2nd Ed. APCA (2012) 6
Step 1 – mild pain: non-opioids
Ibuprofen (NSAID)
• Adult dose: 400mg by mouth every 6-8 hours; maximum daily
dose 1.2g
• Give with food and avoid in asthmatic patients
• The maximum dosing limit should be lowered in patients with
liver impairment
Beating Pain, 2nd Ed. APCA (2012) 7
Step 1 – mild pain: non-opioids
Diclofenac (NSAID)
• Adult dose: 50mg by mouth every 8 hours; maximum daily
dose 150mg
• Give with food and avoid in asthmatic patients
Beating Pain, 2nd Ed. APCA (2012) 8
Cautions with NSAIDs
NSAIDs can cause serious side effects, particularly after using for
more than 7-10 days
• Gastro-intestinal (GI) bleeding or renal toxicity
– If GI symptoms occur, stop and give H2 receptor antagonist.
e.g. Ranitidine
• Not for use in patients with renal failure
Beating Pain, 2nd Ed. APCA (2012) 9
Step 2 – moderate pain: weak opioids
Tramadol
• Adult dose: 50-100mg by mouth every 4-6 hours
• Start with a regular dose and increase if no response (dose
limit: 400mg/day)
• Use with caution in epileptic cases, especially if patient is
taking other drugs that lower the seizure threshold
• May cause serotonin syndrome in patients on other
serotonergic medications
Beating Pain, 2nd Ed. APCA (2012) 10
Step 2 – moderate pain: weak opioids
Codeine
• Adult dose: 30-60mg by mouth every 4 hours; maximum daily
dose 240mg
• If pain relief is not achieved with 240mg/day, move to strong
opioid
• Can be combined with Step 1 analgesic
• Give laxative to avoid constipation unless patient has
diarrhoea
• Genetic variability can lead to variable rates of metabolism
which may make codeine ineffective or lead to excessive
side effects
Beating Pain, 2nd Ed. APCA (2012) 11
Step 2 – moderate pain: weak opioids
Low-dose morphine
• Some palliative care experts recommend using low-dose
morphine in step 2 because it is associated with fewer side
effects compared to other weak opioids
Beating Pain, 2nd Ed. APCA (2012) 12
Step 3 – severe pain: strong opioids
Morphine
• “Gold standard” against which other opioid analgesics are
measured
• When used correctly, patients don’t become dependent or
addicted, tolerance is uncommon, and respiratory depression
doesn’t usually occur
Beating Pain, 2nd Ed. APCA (2012) 13
Step 3 – severe pain: strong opioids
Less commonly used strong opioids (covered in separate lecture)
• Fentanyl
• Oxycodone
• Hydromorphone
• Methadone
Beating Pain, 2nd Ed. APCA (2012) 14
Step 3 – severe pain: strong opioids
Morphine
• Adult starting dose: 2.5–20mg by mouth every 4 hours
depending on age, previous use of opiates, etc.
– Patients changing from regular administration of a Step 2
opioid: 10mg by mouth every 4 hours
– If the patient has experienced weight loss from sickness or
has not progressed onto Step 2 analgesics: 5mg by mouth
every 4 hours
– Frail or elderly patients: 2.5mg by mouth every 6 to 8
hours due to the likelihood of impaired renal function
Beating Pain, 2nd Ed. APCA (2012) 15
Step 3 – severe pain: strong opioids
• Morphine is available as immediate-release or sustained-
release formulations
• Immediate-release
– Dose every 4 hours
– Use to titrate starting dose and treat breakthrough pain
Beating Pain, 2nd Ed. APCA (2012). 16
Step 3 – severe pain: strong opioids
• Sustained-release (or slow-release)
– Dose every 8-24 hours, depending on the formulation
– After determining daily dose with immediate-release
morphine, can change to sustained-release morphine,
being careful to adjust dose as needed to maintain the
total daily dose
• Priority should be given to making immediate-release
formulations available
Beating Pain, 2nd Ed. APCA (2012). 17
Step 3 – severe pain: strong opioids
Morphine
• Increase dose gradually until pain is controlled
• The correct morphine dose is the one that gives pain relief
without side effects: there is no ‘ceiling’ or maximum dose
Beating Pain, 2nd Ed. APCA (2012) 18
Caution: pethidine
Pethidine is not suitable for patients with chronic pain
• It has a faster onset of action and a shorter duration of action
than morphine and needs more frequent dosing: every 2–3
hours
• Pethidine is metabolised to norpethidine which has side
effects inducing central nervous system excitability including
mood changes, tremors, myoclonus (sudden jerking of the
limbs) and convulsions
• Pethidine was removed from the WHO essential medicines list
in 2003 because it was judged to be inferior to morphine due
to its toxicity on the central nervous system and is generally
more expensive than morphine
Beating Pain, 2nd Ed. APCA (2012); The Selection and Use of Essential Medicines – WHO Technical Report Series, No. 920. 2003. 19
Treatment principles
• By the mouth: Use the oral route whenever possible
• By the clock: Administer analgesics according to regular
schedule based on duration of effectiveness rather than “as
needed”, except when titrating dose
• By the ladder: Use the WHO analgesic ladder. If after giving
the optimum dose an analgesic does not control pain, move
up the ladder; do not move sideways in the same level
• By the patient: The right dose is the one that relieves pain.
Titrate the dose upwards until pain is relieved or side effects
prevent moving up further
Beating Pain, 2nd Ed. APCA (2012) 20
Stopping or changing opioids
• When stopping an opioid, reduce daily dose by 25% each day
to avoid symptoms of withdrawal
• When changing from one opioid to another, be mindful of
the need to convert doses
– Check reference materials or consult an expert
Oxford Textbook of Palliative Medicine (2010) 21
Key treatment principle: prophylactic laxatives
• All patients on opioids are at high risk for constipation, and
laxatives should be ordered unless contraindicated
Beating Pain, 2nd Ed. APCA (2012) 22
Take home message
23
• The WHO ladder, an important tool of managing pain, can
effectively treat 80-90% of the patients at this facility
• For non-responsive pain, please refer to a pain specialist
Practical Assessment
24
Esther, a 28 year-old woman with cancer, reports a pain score of 5 out
of 10. Which medicines would you consider prescribing?
A. Codeine
B. Tramadol
C. Low-dose morphine
D. Any of the above
If you prescribe low-dose morphine, what is Esther’s starting dose?
2.5mg every four hours
What other prescriptions must be written at the same time?
Laxatives
References
• African Palliative Care Association. Beating Pain: a pocketguide for pain
management in Africa, 2nd Ed. [Internet]. 2012. Available from:
http://www.africanpalliativecare.org/images/stories/pdf/beating_pain.pdf
• African Palliative Care Association. Using opioids to manage pain: a pocket guide
for health professionals in Africa [Internet]. 2010. Available from:
http://www.africanpalliativecare.org/images/stories/pdf/using_opiods.pdf
• Amery J, editor. Children’s Palliative Care in Africa [Internet]. 2009. Available from:
http://www.icpcn.org/wp-content/uploads/2013/08/Childrens-Palliative-Care-in-
Africa-Full-Text.pdf
• Kopf A, Patel N, editors. Guide to Pain Management in Low-Resource Settings
[Internet]. 2010. Available from: http://www.iasp-
pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Guide_to_Pain_
Management_in_Low-Resource_Settings.pdf
• The Palliative Care Association of Uganda and the Uganda Ministry of Health.
Introductory Palliative Care Course for Healthcare Professionals. 2013.
25

More Related Content

What's hot (20)

INCREASED INTRACRANIAL PRESSURE
INCREASED INTRACRANIAL PRESSUREINCREASED INTRACRANIAL PRESSURE
INCREASED INTRACRANIAL PRESSURE
 
Hyperkalemia and its management
Hyperkalemia and its managementHyperkalemia and its management
Hyperkalemia and its management
 
Multiple organ dysfunction syndrome
Multiple organ dysfunction syndromeMultiple organ dysfunction syndrome
Multiple organ dysfunction syndrome
 
Day case surgery
Day case surgeryDay case surgery
Day case surgery
 
Post Operative Care & Complication
Post Operative Care  & ComplicationPost Operative Care  & Complication
Post Operative Care & Complication
 
Status Epilepticus
Status EpilepticusStatus Epilepticus
Status Epilepticus
 
Ischaemic stroke
Ischaemic stroke Ischaemic stroke
Ischaemic stroke
 
Febrile neutropenia
Febrile neutropeniaFebrile neutropenia
Febrile neutropenia
 
Day care surgery by manjusb
Day care surgery by manjusbDay care surgery by manjusb
Day care surgery by manjusb
 
Post op pyrexia
Post op pyrexiaPost op pyrexia
Post op pyrexia
 
General Anesthesia
General AnesthesiaGeneral Anesthesia
General Anesthesia
 
Preoperative managment
Preoperative managment Preoperative managment
Preoperative managment
 
Febrile neutropenia (2)
Febrile neutropenia (2)Febrile neutropenia (2)
Febrile neutropenia (2)
 
Management of patient with increased intracranial pressure
Management of patient with increased intracranial pressureManagement of patient with increased intracranial pressure
Management of patient with increased intracranial pressure
 
Management of epilepsy
Management of epilepsyManagement of epilepsy
Management of epilepsy
 
Management of seizures
Management of seizuresManagement of seizures
Management of seizures
 
Sirs Mods
Sirs ModsSirs Mods
Sirs Mods
 
Principles of preoperative assessment
Principles of preoperative assessmentPrinciples of preoperative assessment
Principles of preoperative assessment
 
Status epilepticus
Status epilepticusStatus epilepticus
Status epilepticus
 
Extravasation management (1) (1)
Extravasation management (1) (1)Extravasation management (1) (1)
Extravasation management (1) (1)
 

Similar to 4. WHO analgesic ladder.pptx

7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptxtesfkeb
 
5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptxtesfkeb
 
KetamineFINALdraft
KetamineFINALdraftKetamineFINALdraft
KetamineFINALdraftIrena Surina
 
Pharmacological and non pharmacological treatment of primary headaches
Pharmacological and non pharmacological treatment of primary headachesPharmacological and non pharmacological treatment of primary headaches
Pharmacological and non pharmacological treatment of primary headacheswael ezzat
 
Premedicant drugs in Anesthesia
Premedicant drugs in AnesthesiaPremedicant drugs in Anesthesia
Premedicant drugs in AnesthesiaVaishali Syal
 
Pain+management+in+dementia april 2012
Pain+management+in+dementia april 2012Pain+management+in+dementia april 2012
Pain+management+in+dementia april 2012Ihsaan Peer
 
Medications for pain & inflammation
Medications for pain & inflammationMedications for pain & inflammation
Medications for pain & inflammationshayiamk
 
Demystifying Opioid Rotations: The Phantom Menace or A New Hope
Demystifying Opioid Rotations: The Phantom Menace or A New Hope   Demystifying Opioid Rotations: The Phantom Menace or A New Hope
Demystifying Opioid Rotations: The Phantom Menace or A New Hope Christopher B. Ralph
 
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTISedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTIapollobgslibrary
 
Opiate-Analgesics.pptx
Opiate-Analgesics.pptxOpiate-Analgesics.pptx
Opiate-Analgesics.pptxHakeemAlAzizi
 
Adhd treatment updates
Adhd treatment updatesAdhd treatment updates
Adhd treatment updatesYasir Hameed
 

Similar to 4. WHO analgesic ladder.pptx (20)

7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx7. Side effects and toxicity of analgesics (2).pptx
7. Side effects and toxicity of analgesics (2).pptx
 
5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx5. Adjuvants or CoAnalgesics (2).pptx
5. Adjuvants or CoAnalgesics (2).pptx
 
Pain management
Pain managementPain management
Pain management
 
Opioid pain surgery2010
Opioid pain surgery2010Opioid pain surgery2010
Opioid pain surgery2010
 
Session 10 rieb medication management
Session 10  rieb medication managementSession 10  rieb medication management
Session 10 rieb medication management
 
Symptom april2012
Symptom april2012Symptom april2012
Symptom april2012
 
KetamineFINALdraft
KetamineFINALdraftKetamineFINALdraft
KetamineFINALdraft
 
Pharmacological and non pharmacological treatment of primary headaches
Pharmacological and non pharmacological treatment of primary headachesPharmacological and non pharmacological treatment of primary headaches
Pharmacological and non pharmacological treatment of primary headaches
 
Premedicant drugs in Anesthesia
Premedicant drugs in AnesthesiaPremedicant drugs in Anesthesia
Premedicant drugs in Anesthesia
 
Pain+management+in+dementia april 2012
Pain+management+in+dementia april 2012Pain+management+in+dementia april 2012
Pain+management+in+dementia april 2012
 
Palliation of Pain
Palliation of PainPalliation of Pain
Palliation of Pain
 
Palliation of Pain
Palliation of PainPalliation of Pain
Palliation of Pain
 
Medications for pain & inflammation
Medications for pain & inflammationMedications for pain & inflammation
Medications for pain & inflammation
 
Breakout C1 Franklin TFME
Breakout C1 Franklin TFMEBreakout C1 Franklin TFME
Breakout C1 Franklin TFME
 
Demystifying Opioid Rotations: The Phantom Menace or A New Hope
Demystifying Opioid Rotations: The Phantom Menace or A New Hope   Demystifying Opioid Rotations: The Phantom Menace or A New Hope
Demystifying Opioid Rotations: The Phantom Menace or A New Hope
 
Opioid analgesics
Opioid analgesicsOpioid analgesics
Opioid analgesics
 
dr-170826095415.pptx
dr-170826095415.pptxdr-170826095415.pptx
dr-170826095415.pptx
 
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTISedation & Paralysis in ICU- DR.RAGHUNATH   ALADAKATTI
Sedation & Paralysis in ICU- DR.RAGHUNATH ALADAKATTI
 
Opiate-Analgesics.pptx
Opiate-Analgesics.pptxOpiate-Analgesics.pptx
Opiate-Analgesics.pptx
 
Adhd treatment updates
Adhd treatment updatesAdhd treatment updates
Adhd treatment updates
 

Recently uploaded

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxAnaBeatriceAblay2
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaVirag Sontakke
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,Virag Sontakke
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTiammrhaywood
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Sapana Sha
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxNirmalaLoungPoorunde1
 

Recently uploaded (20)

POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptxENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
ENGLISH5 QUARTER4 MODULE1 WEEK1-3 How Visual and Multimedia Elements.pptx
 
Painted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of IndiaPainted Grey Ware.pptx, PGW Culture of India
Painted Grey Ware.pptx, PGW Culture of India
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
9953330565 Low Rate Call Girls In Rohini Delhi NCR
9953330565 Low Rate Call Girls In Rohini  Delhi NCR9953330565 Low Rate Call Girls In Rohini  Delhi NCR
9953330565 Low Rate Call Girls In Rohini Delhi NCR
 
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,भारत-रोम व्यापार.pptx, Indo-Roman Trade,
भारत-रोम व्यापार.pptx, Indo-Roman Trade,
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPTECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
ECONOMIC CONTEXT - LONG FORM TV DRAMA - PPT
 
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111Call Girls in Dwarka Mor Delhi Contact Us 9654467111
Call Girls in Dwarka Mor Delhi Contact Us 9654467111
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Staff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSDStaff of Color (SOC) Retention Efforts DDSD
Staff of Color (SOC) Retention Efforts DDSD
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Employee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptxEmployee wellbeing at the workplace.pptx
Employee wellbeing at the workplace.pptx
 

4. WHO analgesic ladder.pptx

  • 1. WHO Analgesic Ladder By James Kateregga
  • 2. Objectives • Review the World Health Organization (WHO) analgesic ladder • Discuss treatment for treat mild, moderate, or severe pain • Review additional treatment principles when using opioids 2
  • 3. Background • The WHO analgesic ladder was introduced in 1986 – 3-step ladder for adults – Updated in 2012 to include 2-step ladder for children • Framework for pharmacological management of pain • 80-90% of patients are effectively treated using the WHO 3- step approach http://www.who.int/cancer/palliative/painladder/en/ 3
  • 4. 4 Mild pain Moderate pain Severe pain Step 1 Non-opioid Step 2 Weak opioid Step 3 Strong opioid +/- adjuvant +/- non-opioid +/- adjuvant +/- non-opioid +/- adjuvant Consider prophylactic laxatives to avoid constipation Step up if pain persists or increases Step up if pain persists or increases Non-opioids ibuprofen or other NSAID, paracetamol (acetaminophen), or aspirin Weak opioids codeine, tramadol, or low-dose morphine Strong opioids morphine, fentanyl, oxycodone, hydromorphone, buprenorphine Adjuvants antidepressant, anticonvulsant, antispasmodic, muscle relaxant, bisphosphonate, or corticosteroid Combining an opioid and non-opioid is effective, but do not combine drugs of the same class. Time doses based on drug half-life (“dose by the clock”); do not wait for pain to recur Adapted by Treat the Pain from World Health Organization http://www.who.int/cancer/palliative/painladder/en/ (accessed 7 November 2013) WHO Analgesic Ladder: adults 4
  • 5. Using the WHO ladder for adults Beating Pain, 2nd Ed. APCA (2012) 5 • Mild pain - start with a non-opioid, for example with regular paracetamol or non- steroidal anti-inflammatory drug (NSAID), then move up steps if pain remains uncontrolled • Moderate - start with a weak opioid, for example, codeine or low-dose morphine • Severe - start with a strong opioid, for example, morphine, to control pain early • Adjuvants can be used at any step
  • 6. Step 1 – mild pain: non-opioids Paracetamol • Adult dose: 500mg-1g by mouth every 6 hours; maximum daily dose 4g • Note: Hepatoxicity can occur if more than the maximum dose is given per day • Paracetamol can be combined with an NSAID Beating Pain, 2nd Ed. APCA (2012) 6
  • 7. Step 1 – mild pain: non-opioids Ibuprofen (NSAID) • Adult dose: 400mg by mouth every 6-8 hours; maximum daily dose 1.2g • Give with food and avoid in asthmatic patients • The maximum dosing limit should be lowered in patients with liver impairment Beating Pain, 2nd Ed. APCA (2012) 7
  • 8. Step 1 – mild pain: non-opioids Diclofenac (NSAID) • Adult dose: 50mg by mouth every 8 hours; maximum daily dose 150mg • Give with food and avoid in asthmatic patients Beating Pain, 2nd Ed. APCA (2012) 8
  • 9. Cautions with NSAIDs NSAIDs can cause serious side effects, particularly after using for more than 7-10 days • Gastro-intestinal (GI) bleeding or renal toxicity – If GI symptoms occur, stop and give H2 receptor antagonist. e.g. Ranitidine • Not for use in patients with renal failure Beating Pain, 2nd Ed. APCA (2012) 9
  • 10. Step 2 – moderate pain: weak opioids Tramadol • Adult dose: 50-100mg by mouth every 4-6 hours • Start with a regular dose and increase if no response (dose limit: 400mg/day) • Use with caution in epileptic cases, especially if patient is taking other drugs that lower the seizure threshold • May cause serotonin syndrome in patients on other serotonergic medications Beating Pain, 2nd Ed. APCA (2012) 10
  • 11. Step 2 – moderate pain: weak opioids Codeine • Adult dose: 30-60mg by mouth every 4 hours; maximum daily dose 240mg • If pain relief is not achieved with 240mg/day, move to strong opioid • Can be combined with Step 1 analgesic • Give laxative to avoid constipation unless patient has diarrhoea • Genetic variability can lead to variable rates of metabolism which may make codeine ineffective or lead to excessive side effects Beating Pain, 2nd Ed. APCA (2012) 11
  • 12. Step 2 – moderate pain: weak opioids Low-dose morphine • Some palliative care experts recommend using low-dose morphine in step 2 because it is associated with fewer side effects compared to other weak opioids Beating Pain, 2nd Ed. APCA (2012) 12
  • 13. Step 3 – severe pain: strong opioids Morphine • “Gold standard” against which other opioid analgesics are measured • When used correctly, patients don’t become dependent or addicted, tolerance is uncommon, and respiratory depression doesn’t usually occur Beating Pain, 2nd Ed. APCA (2012) 13
  • 14. Step 3 – severe pain: strong opioids Less commonly used strong opioids (covered in separate lecture) • Fentanyl • Oxycodone • Hydromorphone • Methadone Beating Pain, 2nd Ed. APCA (2012) 14
  • 15. Step 3 – severe pain: strong opioids Morphine • Adult starting dose: 2.5–20mg by mouth every 4 hours depending on age, previous use of opiates, etc. – Patients changing from regular administration of a Step 2 opioid: 10mg by mouth every 4 hours – If the patient has experienced weight loss from sickness or has not progressed onto Step 2 analgesics: 5mg by mouth every 4 hours – Frail or elderly patients: 2.5mg by mouth every 6 to 8 hours due to the likelihood of impaired renal function Beating Pain, 2nd Ed. APCA (2012) 15
  • 16. Step 3 – severe pain: strong opioids • Morphine is available as immediate-release or sustained- release formulations • Immediate-release – Dose every 4 hours – Use to titrate starting dose and treat breakthrough pain Beating Pain, 2nd Ed. APCA (2012). 16
  • 17. Step 3 – severe pain: strong opioids • Sustained-release (or slow-release) – Dose every 8-24 hours, depending on the formulation – After determining daily dose with immediate-release morphine, can change to sustained-release morphine, being careful to adjust dose as needed to maintain the total daily dose • Priority should be given to making immediate-release formulations available Beating Pain, 2nd Ed. APCA (2012). 17
  • 18. Step 3 – severe pain: strong opioids Morphine • Increase dose gradually until pain is controlled • The correct morphine dose is the one that gives pain relief without side effects: there is no ‘ceiling’ or maximum dose Beating Pain, 2nd Ed. APCA (2012) 18
  • 19. Caution: pethidine Pethidine is not suitable for patients with chronic pain • It has a faster onset of action and a shorter duration of action than morphine and needs more frequent dosing: every 2–3 hours • Pethidine is metabolised to norpethidine which has side effects inducing central nervous system excitability including mood changes, tremors, myoclonus (sudden jerking of the limbs) and convulsions • Pethidine was removed from the WHO essential medicines list in 2003 because it was judged to be inferior to morphine due to its toxicity on the central nervous system and is generally more expensive than morphine Beating Pain, 2nd Ed. APCA (2012); The Selection and Use of Essential Medicines – WHO Technical Report Series, No. 920. 2003. 19
  • 20. Treatment principles • By the mouth: Use the oral route whenever possible • By the clock: Administer analgesics according to regular schedule based on duration of effectiveness rather than “as needed”, except when titrating dose • By the ladder: Use the WHO analgesic ladder. If after giving the optimum dose an analgesic does not control pain, move up the ladder; do not move sideways in the same level • By the patient: The right dose is the one that relieves pain. Titrate the dose upwards until pain is relieved or side effects prevent moving up further Beating Pain, 2nd Ed. APCA (2012) 20
  • 21. Stopping or changing opioids • When stopping an opioid, reduce daily dose by 25% each day to avoid symptoms of withdrawal • When changing from one opioid to another, be mindful of the need to convert doses – Check reference materials or consult an expert Oxford Textbook of Palliative Medicine (2010) 21
  • 22. Key treatment principle: prophylactic laxatives • All patients on opioids are at high risk for constipation, and laxatives should be ordered unless contraindicated Beating Pain, 2nd Ed. APCA (2012) 22
  • 23. Take home message 23 • The WHO ladder, an important tool of managing pain, can effectively treat 80-90% of the patients at this facility • For non-responsive pain, please refer to a pain specialist
  • 24. Practical Assessment 24 Esther, a 28 year-old woman with cancer, reports a pain score of 5 out of 10. Which medicines would you consider prescribing? A. Codeine B. Tramadol C. Low-dose morphine D. Any of the above If you prescribe low-dose morphine, what is Esther’s starting dose? 2.5mg every four hours What other prescriptions must be written at the same time? Laxatives
  • 25. References • African Palliative Care Association. Beating Pain: a pocketguide for pain management in Africa, 2nd Ed. [Internet]. 2012. Available from: http://www.africanpalliativecare.org/images/stories/pdf/beating_pain.pdf • African Palliative Care Association. Using opioids to manage pain: a pocket guide for health professionals in Africa [Internet]. 2010. Available from: http://www.africanpalliativecare.org/images/stories/pdf/using_opiods.pdf • Amery J, editor. Children’s Palliative Care in Africa [Internet]. 2009. Available from: http://www.icpcn.org/wp-content/uploads/2013/08/Childrens-Palliative-Care-in- Africa-Full-Text.pdf • Kopf A, Patel N, editors. Guide to Pain Management in Low-Resource Settings [Internet]. 2010. Available from: http://www.iasp- pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Guide_to_Pain_ Management_in_Low-Resource_Settings.pdf • The Palliative Care Association of Uganda and the Uganda Ministry of Health. Introductory Palliative Care Course for Healthcare Professionals. 2013. 25